A seasoned scientist, public health expert, and entrepreneur, Syreen Goulmamine delivers results-driven strategies that connect science to social impact. She is the Founder & Chief Executive Officer of EquityBio Consulting, where she collaborates with researchers, policymakers, community organizations, and industry leaders to identify and address care gaps, translate research into actionable insights, and implement inclusive, evidence-based solutions.

In addition to leading her consultancy, Goulmamine serves as Programs Manager at the Society for Women’s Health Research. Managing a diverse portfolio of diseases and conditions that uniquely, disproportionately, and differently impact women, she excels in program management, stakeholder engagement, data analysis, research translation & content development. With a background spanning epidemiology, laboratory management, clinical trials, and public health practice, Goulmamine has previously worked for and consulted at Fortune 500 companies, biotech startups, state and local health departments, and non-profits.

Goulmamine is an active leader in local, state, and national health initiatives, serving on the U.S. Food and Drug Administration (FDA) and Clinical Trials Transformation Initiative (CTTI)’s Patient Engagement Collaborative, Virginia Diabetes Council Board of Directors, AcademyHealth’s Health Equity Interest Group Advisory Committee, George Mason University’s College of Public Health Alumni Board, Randolph-Macon College’s Physician Assistant Program Advisory Committee, and sits on the Rare Disease Diversity Coalition’s Patient, Provider, Caregiver Journey Working Group, and T1D International Federal Policy Working Group.

Goulmamine is currently pursuing her Doctor of Public Health (Implementation & Evaluation Sciences) from Emory University. She previously earned her Master of Public Health (Epidemiology) from George Mason University and a Bachelor of Science from Randolph-Macon College. Her academic excellence has earned her membership in the Beta Beta Beta Biological Honor Society and the Delta Omega National Honor Society.